---
title: "JI LIN AO DONG: The hydrochloride naloxone injection has passed the consistency evaluation of quality and efficacy for generic drugs"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/261828868.md"
description: "JI LIN AO DONG announced that its holding subsidiary Yanji Pharmaceutical has received the \"Drug Supplement Application Approval Notice\" for \"Naloxone Hydrochloride Injection\" issued by the National Medical Products Administration. The generic name of the drug is Naloxone Hydrochloride Injection, with a specification of 1ml: 0.4mg, and the original drug approval number is Guo Yao Zhun Zi H20066188. This approval through the consistency evaluation of the quality and efficacy of generic drugs is beneficial for expanding the market share of this drug and enhancing market competitiveness. It is expected that there will be no significant impact on the company's performance in the short term"
datetime: "2025-10-20T07:44:42.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/261828868.md)
  - [en](https://longbridge.com/en/news/261828868.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/261828868.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/261828868.md) | [繁體中文](https://longbridge.com/zh-HK/news/261828868.md)


# JI LIN AO DONG: The hydrochloride naloxone injection has passed the consistency evaluation of quality and efficacy for generic drugs

JI LIN AO DONG announced that its holding subsidiary Yanji Pharmaceutical has received the "Drug Supplement Application Approval Notice" for "Naloxone Hydrochloride Injection" issued by the National Medical Products Administration. The drug's generic name is Naloxone Hydrochloride Injection, with a specification of 1ml: 0.4mg, and the original drug approval number is Guo Yao Zhun Zi H20066188. The approval of the consistency evaluation of the quality and efficacy of the generic drug is beneficial for expanding the market share of this drug and enhancing market competitiveness. It is expected that there will be no significant impact on the company's performance in the short term

### Related Stocks

- [JI LIN AO DONG (000623.CN)](https://longbridge.com/en/quote/000623.CN.md)

## Related News & Research

- [Glenmark Pharmaceuticals Unit to Launch Sodium Phosphates Injection](https://longbridge.com/en/news/277144458.md)
- [Changchun High-Tech Industry Files Clinical Trial Application for GenSci161 Injection](https://longbridge.com/en/news/277574518.md)
- [Soon after administering Narcan to DUI suspect, CHP officer died from ingesting fentanyl](https://longbridge.com/en/news/276774544.md)
- [RBC's Bullock: An oil supply shock could add to inflation pressures](https://longbridge.com/en/news/277520686.md)
- [12:12 ETWFSA Honors Franco and Pietro Gussalli Beretta with the Dr. Vito Genco Shooting Ambassador Award](https://longbridge.com/en/news/277076654.md)